Fundamental mistuning model for determining system properties and predicting vibratory response of bladed disks von FEINER DREW M, GRIFFIN JERRY HOWARD

Volltext bestellen

Fundamental mistuning model for determining system properties and predicting vibratory response of bladed disks von Griffin, Jerry Howard, Feiner, Drew M

Volltext bestellen

Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscu... von Mendell, Jerry R, Shieh, Perry B, McDonald, Craig M, Sahenk, Zarife, Lehman, Kelly J, Lowes, Linda P, Reash, Natalie F, Iammarino, Megan A, Alfano, Lindsay N, Sabo, Brenna, Woods, Jeremy D, Skura, Christy L, Mao, Howard C, Staudt, Loretta A, Griffin, Danielle A, Lewis, Sarah, Wang, Shufang, Potter, Rachael A, Singh, Teji, Rodino-Klapac, Louise R

Volltext

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial von McInnes, Iain B, Dr, Kavanaugh, Arthur, Prof, Gottlieb, Alice B, MD, Puig, Lluís, MD, Rahman, Proton, MD, Ritchlin, Christopher, MD, Brodmerkel, Carrie, PhD, Li, Shu, PhD, Wang, Yuhua, PhD, Mendelsohn, Alan M, MD, Doyle, Mittie K, MD

Volltext

A Phase 2 Clinical Trial Evaluating the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Patients with Duchenne Muscular Dystrophy (DMD) (S48.004) von Mendell, Jerry, Shieh, Perry, Sahenk, Zarife, Lehman, Kelly, Lowes, Linda, Reash, Natalie, Iammarino, Megan, Alfano, Lindsay, Sabo, Brenna, Woods, Jeremy, Skura, Christy, Mao, Howard, Staudt, Loretta, Potter, Rachael, Griffin, Danielle, Lewis, Sarah, Wang, Shufang, Singh, Tejdip, Rodino-Klapac, Louise

Volltext

A Multicenter Randomized, Double-Blind, Placebo-Controlled, Gene-Delivery Clinical Trial of rAAVrh74.MHCK7.micro-dystrophin for Duchenne Muscular Dystrophy (4478) von Mendell, Jerry, Shieh, Perry, Sahenk, Zarife, Lehman, Kelly, Lowes, Linda, Miller, Natalie, Iammarino, Megan, Alfano, Lindsay, Woods, Jeremy, Skura, Christy, Mao, Howard, Staudt, Loretta, Potter, Rachael, Griffin, Danielle, Lewis, Sarah, Hu, Larry, Upadhyay, Sameer, Singh, Teji, Rodino-Klapac, Louise

Volltext

A Phase 2 Clinical Trial Evaluating the Safety and Efficacy of SRP-9001 for Treating Patients with Duchenne Muscular Dystrophy (S23.002) von Mendell, Jerry R., Shieh, Perry B., Sahenk, Zarife, Lehman, Kelly J., Lowes, Linda P., Reash, Natalie F., Iammarino, Megan A., Alfano, Lindsay N., Powers, Brenna, Woods, Jeremy D., Skura, Christy L., Mao, Howard C., Staudt, Loretta A., Potter, Rachael A., Griffin, Danielle A., Lewis, Sarah, Hu, Larry, Upadhyay, Sameer, Singh, Teji, Rodino-Klapac, Louise R.

Volltext

eP201: A phase 2 clinical trial evaluating the safety and efficacy of delandistrogene moxeparvovec for treating patients with Duchenne muscular dystrophy von O'Rourke, Erin, Mendell, Jerry, Shieh, Perry, Sahenk, Zarife, Lehman, Kelly, Lowes, Linda, Reash, Natalie, Iammarino, Megan, Alfano, Lindsay, Powers, Brenna, Woods, Jeremy, Skura, Christy, Mao, Howard, Staudt, Loretta, Potter, Rachael, Griffin, Danielle, Lewis, Sarah, Upadhyay, Sameer, Singh, Teji, Rodino-Klapac, Louise

Volltext

Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials: Ad hoc panel on endpoints for diabetic neuropathy trials von APFEL, Stuart C, ASBURY, Arthur K, GRANT, Ian A, GRIFFIN, John W, KLEIN, Christopher J, LINDBLOM, Ulf, LITCHY, William J, LOW, Phillip A, MELANSON, Michel, MENDELL, Jerry R, MERREN, Michael D, O, Peter C, BRIL, Vera, BRIEN, RENDELL, Marc, RIZZA, Robert A, SERVICE, F. John, THOMAS, P. K, WALK, David, WANG, Annabel K, WESSEL, Klaus, WINDEBANK, Anthony J, ZIEGLER, Dan, BURNS, Ted M, ZOCHODNE, Douglas W, CAMPBELL, James N, CHALK, Colin H, DYCK, Peter J, DYCK, P. James B, FELDMAN, Eva L, FIELDS, Howard L

Volltext